Heart-type fatty acid binding protein level as a tool in identification of early cardiac effects of diabetic ketoacidosis


YILMAZ F. H., Yuca S. A., Vatansev H., CİMBEK E. A., Şen Y., Yılmaz İ., ...Daha Fazla

JCRPE Journal of Clinical Research in Pediatric Endocrinology, cilt.9, sa.2, ss.118-123, 2017 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 9 Sayı: 2
  • Basım Tarihi: 2017
  • Doi Numarası: 10.4274/jcrpe.3961
  • Dergi Adı: JCRPE Journal of Clinical Research in Pediatric Endocrinology
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.118-123
  • Anahtar Kelimeler: Heart-type fatty acid binding protein, child, diabetic ketoacidosis
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objective: This study aimed to measure the serum levels of heart-type fatty acid binding protein (H-FABP) in patients presenting with diabetic ketoacidosis (DKA) and diabetic ketosis (DK) and to determine its role in identifying early-period cardiac ischemia. Methods: This prospective study included 35 patients diagnosed with DKA, 20 patients diagnosed with DK, and 20 control subjects. H-FABP, creatine kinase-MB (CK-MB), and troponin I levels were investigated at presentation in patients with DKA and DK and in the control group. H-FABP values were measured again after acidosis correction in the DKA patients. Results: No statistically significant differences were found with respect to troponin I and CK-MB within the groups. The H-FABP values of DKA patients at presentation were found to be significantly higher than those of DK patients and the control group (p=0.015). The H-FABP value of the DKA group was also found to be significantly higher than the value at hour 36 after acidosis correction (p=0.0001). Conclusion: We would like to propose H-FABP as a potential marker for indicating myocardial ischemia.